Opiant Pharmaceuticals, Inc.

NASDAQ (USD): Opiant Pharmaceuticals, Inc. (OPNT)

Last Price

16.00

Today's Change

-0.15 (0.92%)

Day's Change

15.87 - 16.43

Trading Volume

39,418

Profile
OPNT

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Roger Crystal M.D. Dr. Roger Crystal M.D.

Full Time Employees:  37 37

IPO Date:  2007-06-04 2007-06-04

CIK:  0001385508 0001385508

ISIN:  US6837501039 US6837501039

CUSIP:  683750103 683750103

Beta:  0.83 0.83

Last Dividend:  0.00 0.00

Dcf Diff:  6.05 6.05

Dcf:  26.31 26.31

Description

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Address

233 Wilshirre Boulevard,
Santa Monica, CA 90401, US

310 598 5410

http://www.opiant.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment